|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9608
|
|
pubmed:dateCreated |
2008-1-21
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Evidence suggests that inflammatory mediators contribute to development and progression of chronic heart failure. We therefore tested the hypothesis that immunomodulation might counteract this pathophysiological mechanism in patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
pubmed-author:Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation...,
pubmed-author:AnkerStefan DSD,
pubmed-author:BourgeRobert CRC,
pubmed-author:ColucciWilson SWS,
pubmed-author:GreenbergBarry HBH,
pubmed-author:HildebrandtPerP,
pubmed-author:KerenAndreA,
pubmed-author:MotroMichaelM,
pubmed-author:MoyéLemuel ALA,
pubmed-author:OtterstadJan ErikJE,
pubmed-author:PonikowskiPiotrP,
pubmed-author:PrattCraig MCM,
pubmed-author:RouleauJean LucienJL,
pubmed-author:SestierFrancoisF,
pubmed-author:Torre-AmioneGuillermoG,
pubmed-author:WinkelmannBernhard RBR,
pubmed-author:YoungJames BJB
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
19
|
|
pubmed:volume |
371
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
228-36
|
|
pubmed:dateRevised |
2009-3-26
|
|
pubmed:meshHeading |
pubmed-meshheading:18207018-Aged,
pubmed-meshheading:18207018-Chronic Disease,
pubmed-meshheading:18207018-Double-Blind Method,
pubmed-meshheading:18207018-Endpoint Determination,
pubmed-meshheading:18207018-Female,
pubmed-meshheading:18207018-Heart Failure,
pubmed-meshheading:18207018-Hospital Mortality,
pubmed-meshheading:18207018-Humans,
pubmed-meshheading:18207018-Immunologic Factors,
pubmed-meshheading:18207018-Male,
pubmed-meshheading:18207018-Middle Aged,
pubmed-meshheading:18207018-Severity of Illness Index
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.
|
|
pubmed:affiliation |
Heart Transplant Program, Methodist DeBakey Heart Center, Methodist Hospital, Houston, TX 77030, USA. gtorre@tmhs.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
